Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART 2D: Montelukast in Adolescents and Young Adults With Type 2 Diabetes
NCT07409714Phase 1Recruiting
- Sponsor
- University of Colorado Denver
- Start
- Oct 2026
- Primary completion
- Dec 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial in type 2 diabetes mellitus (T2DM) comparing Montelukast with Placebo (2 arms). Primary endpoint: Renal Vascular Resistance at 6 months. Started Oct 2026; status: recruiting.
02
Drugs
montelukast
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07409714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07409714.